{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T22:41:32.235772+00:00","company":{"ticker":"WVE","cik":1631574,"company_name":"Wave Life Sciences Ltd."},"pagination":{"limit":100,"returned":3,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"feba5bae6690900e05fcbc16447085586890aa2d","cik":1631574,"ticker":"WVE","company_name":"Wave Life Sciences Ltd.","filed_at":"2026-04-28T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"quarter ended March 31, 2026","report_date":"2026-04-28","result_type":"reported_results","revenue_text":null},"claim":"Wave Life Sciences Ltd. reported financial results for quarter ended March 31, 2026.","evidence_excerpt":"On April 28, 2026, Wave Life Sciences Ltd. (the “Company”) announced its financial results for the quarter ended March 31, 2026.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-183563","anchor_url":"https://secwatch.observer/filing/0001193125-26-183563#claim-feba5bae6690900e05fcbc16447085586890aa2d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526183563/0001193125-26-183563-index.htm"},{"fact_type":"material_agreement","fact_key":"c1b123ba460f7ed7d059728f6fe8e0f13e1304c3","cik":1631574,"ticker":"WVE","company_name":"Wave Life Sciences Ltd.","filed_at":"2026-04-15T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Implementation Agreement","agreement_type":"merger","counterparty":"Wave Life Sciences, Inc. (Wave-Delaware)","effective_date":"2026-04-15","item_codes_triggered":["1.01"],"value_text":"Exchange all Wave-Singapore ordinary shares for Wave-Delaware common stock on a one-for-one basis; R"},"claim":"Wave Life Sciences Ltd. entered into Implementation Agreement with Wave Life Sciences, Inc. (Wave-Delaware) valued at Exchange all Wave-Singapore ordinary shares for Wave-Delaware common stock on a one-for-one basis; R (effective 2026-04-15).","evidence_excerpt":"In order to complete the Redomiciliation, the boards of directors of each of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation (“ Wave-Delaware ”), approved the entry by Wave-Singapore and Wave-Delaware, respectively, into an Implementation Agreement (the “ Implementation Agreement ”). The Implementation Agreement was executed by Wave-Singapore and Wave-Delaware on April 15, 2026 and provides for a statutory procedure known as a scheme of arrangement (the “ Scheme of Arrangement ”) to be implemented by Wave-Singapore and Wave-Delaware under Singapore law, subject to approval of the shareholders of Wave-Singapore and the High Court of the Republic of Singapore.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-157003","anchor_url":"https://secwatch.observer/filing/0001193125-26-157003#claim-c1b123ba460f7ed7d059728f6fe8e0f13e1304c3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526157003/0001193125-26-157003-index.htm"},{"fact_type":"earnings_release","fact_key":"4377d486015ac3bf4d8ba36987119cae36e45e47","cik":1631574,"ticker":"WVE","company_name":"Wave Life Sciences Ltd.","filed_at":"2024-05-09T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the quarter ended March 31, 2024","report_date":"2024-05-09","result_type":"reported_results","revenue_text":null},"claim":"Wave Life Sciences Ltd. reported financial results for the quarter ended March 31, 2024.","evidence_excerpt":"On May 9, 2024, Wave Life Sciences Ltd. (the “Company”) announced its financial results for the quarter ended March 31, 2024.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-134769","anchor_url":"https://secwatch.observer/filing/0001193125-24-134769#claim-4377d486015ac3bf4d8ba36987119cae36e45e47","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312524134769/0001193125-24-134769-index.htm"}]}